Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6316287 | 7086387 | I | 6316287-4 | 20090813 | 20090820 | EXP | US-GILEAD-2009-0023664 | GILEAD SCIENCES INC | F | Y | 20090820 | CN | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6316287 | 1012077292 | PS | LETAIRIS | 1 | ORAL | FEN002 | 022081 | ||||
| 6316287 | 1012077293 | C | LASIX | 1 | |||||||
| 6316287 | 1012077294 | C | COREG | 1 | |||||||
| 6316287 | 1012077295 | C | AMIODARONE | 2 | |||||||
| 6316287 | 1012077296 | C | ALDACTONE | 1 | |||||||
| 6316287 | 1012077297 | C | ZAROXOLYN | 1 | |||||||
| 6316287 | 1012077298 | C | IPRATR-ALBUTEROL | 2 | |||||||
| 6316287 | 1012077299 | C | ALBUTEROL | 2 | |||||||
| 6316287 | 1012077300 | C | ADVAIR HFA | 1 | |||||||
| 6316287 | 1012077301 | C | APAP TAB | 1 | |||||||
| 6316287 | 1012077302 | C | REQUIP | 1 | |||||||
| 6316287 | 1012077303 | C | PREVACID | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6316287 | 1012077292 | PULMONARY ARTERIAL HYPERTENSION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6316287 | DE |
Reactions reported
| Event ID | PT |
|---|---|
| 6316287 | DEATH |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6316287 | 1012077292 | 20090312 |